Dr. José Rocha Faria Neto (CRM-PR 16390) comenta dados do estudo que avaliou o alcance de metas de LDL-c.
Referências:
1. Dec A, Niemiec A, Wojciechowska E, et al. Inclisiran-A Revolutionary Addition to a Cholesterol-Lowering Therapy. Int J Mol Sci. 2023 Apr 6;24(7):6858.
Dr Jose Rocha Faria Neto | CRM 16390-PR